{"id":2131,"date":"2024-03-19T18:16:35","date_gmt":"2024-03-19T17:16:35","guid":{"rendered":"https:\/\/tafalgie.fr\/premier-communique-de-presse\/"},"modified":"2024-10-30T16:53:11","modified_gmt":"2024-10-30T15:53:11","slug":"premier-communique-de-presse","status":"publish","type":"post","link":"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/","title":{"rendered":"Premier communiqu\u00e9 de presse"},"content":{"rendered":"\n
<\/div>\n\n\n\n
\n
\n
\n
\n
\n

Tafalgie Therapeutics remporte le programme EIC<\/u><\/h1>\n\n\n\n
<\/div>\n\n\n\n
\n
\n
\n
\n
\"\"<\/figure>\n\n\n\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n

Nous sommes fiers d\u2019annoncer que Tafalgie Therapeutics fait partie des quarante-sept soci\u00e9t\u00e9s europ\u00e9ennes (dont douze fran\u00e7aises) s\u00e9lectionn\u00e9es \u00e0 la suite de l\u2019appel de projets lanc\u00e9 par le Conseil Europ\u00e9en de l\u2019Innovation (the European Innovation Council, EIC<\/em>) en novembre 2023 pour le programme \u00ab Accelerator \u00bb, qui r\u00e9compense des soci\u00e9t\u00e9s faisant preuve d\u2019excellence dans le d\u00e9ploiement d\u2019innovations radicales et novatrices.<\/p>\n\n\n\n

L’EIC acc\u00e9l\u00e9rateur permettra \u00e0 Tafalgie Therapeutics, une startup en biotechnologie localis\u00e9e \u00e0 Marseille, d\u2019acc\u00e9l\u00e9rer le d\u00e9veloppement de sa nouvelle g\u00e9n\u00e9ration de peptides antidouleur comme une alternative aux opio\u00efdes pour le traitement des douleurs aigu\u00ebs et chroniques.<\/p>\n\n\n\n

La prochaine \u00e9tape sera le lancement d\u2019essais cliniques pour d\u00e9montrer l\u2019efficacit\u00e9 chez l\u2019humain.<\/strong><\/p>\n\n\n\n

\n
Lire notre communiqu\u00e9 de presse ici<\/a><\/div>\n<\/div>\n\n\n\n
\n\n\n\n

<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Tafalgie Therapeutics remporte le programme EIC Nous sommes fiers d\u2019annoncer que Tafalgie Therapeutics fait partie des quarante-sept soci\u00e9t\u00e9s europ\u00e9ennes (dont douze fran\u00e7aises) s\u00e9lectionn\u00e9es \u00e0 la suite de l\u2019appel de projets lanc\u00e9 par le Conseil Europ\u00e9en de l\u2019Innovation (the European Innovation Council, EIC) en novembre 2023 pour le programme \u00ab Accelerator \u00bb, qui r\u00e9compense des soci\u00e9t\u00e9s faisant preuve […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[75],"tags":[],"class_list":["post-2131","post","type-post","status-publish","format-standard","hentry","category-communiques-de-presse"],"acf":[],"yoast_head":"\nPremier communiqu\u00e9 de presse - Tafalgie Therapeutics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Premier communiqu\u00e9 de presse - Tafalgie Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Tafalgie Therapeutics remporte le programme EIC Nous sommes fiers d\u2019annoncer que Tafalgie Therapeutics fait partie des quarante-sept soci\u00e9t\u00e9s europ\u00e9ennes (dont douze fran\u00e7aises) s\u00e9lectionn\u00e9es \u00e0 la suite de l\u2019appel de projets lanc\u00e9 par le Conseil Europ\u00e9en de l\u2019Innovation (the European Innovation Council, EIC) en novembre 2023 pour le programme \u00ab Accelerator \u00bb, qui r\u00e9compense des soci\u00e9t\u00e9s faisant preuve […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/\" \/>\n<meta property=\"og:site_name\" content=\"Tafalgie Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-19T17:16:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-30T15:53:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_94576008-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1703\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tafalgie_client_23\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tafalgie_client_23\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/\"},\"author\":{\"name\":\"Tafalgie_client_23\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/#\/schema\/person\/00336a1fe4b9683bda250c48cef99f56\"},\"headline\":\"Premier communiqu\u00e9 de presse\",\"datePublished\":\"2024-03-19T17:16:35+00:00\",\"dateModified\":\"2024-10-30T15:53:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/\"},\"wordCount\":152,\"publisher\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_94576008-scaled.jpeg\",\"articleSection\":[\"Communiqu\u00e9s de presse\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/\",\"url\":\"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/\",\"name\":\"Premier communiqu\u00e9 de presse - Tafalgie Therapeutics\",\"isPartOf\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_94576008-scaled.jpeg\",\"datePublished\":\"2024-03-19T17:16:35+00:00\",\"dateModified\":\"2024-10-30T15:53:11+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/#primaryimage\",\"url\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_94576008-scaled.jpeg\",\"contentUrl\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_94576008-scaled.jpeg\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/#website\",\"url\":\"https:\/\/tafalgie.fr\/fr\/\",\"name\":\"Tafalgie Therapeutics\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tafalgie.fr\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/#organization\",\"name\":\"Tafalgie Therapeutics\",\"url\":\"https:\/\/tafalgie.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/01\/logo-tafalgie-HD-02-1024x286-1.png\",\"contentUrl\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/01\/logo-tafalgie-HD-02-1024x286-1.png\",\"width\":1024,\"height\":286,\"caption\":\"Tafalgie Therapeutics\"},\"image\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/#\/schema\/person\/00336a1fe4b9683bda250c48cef99f56\",\"name\":\"Tafalgie_client_23\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1777915955\",\"url\":\"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1777915955\",\"contentUrl\":\"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1777915955\",\"caption\":\"Tafalgie_client_23\"},\"sameAs\":[\"http:\/\/tafalgie.fr\"],\"url\":\"https:\/\/tafalgie.fr\/fr\/author\/tafalgie_client_23\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Premier communiqu\u00e9 de presse - Tafalgie Therapeutics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/","og_locale":"fr_FR","og_type":"article","og_title":"Premier communiqu\u00e9 de presse - Tafalgie Therapeutics","og_description":"Tafalgie Therapeutics remporte le programme EIC Nous sommes fiers d\u2019annoncer que Tafalgie Therapeutics fait partie des quarante-sept soci\u00e9t\u00e9s europ\u00e9ennes (dont douze fran\u00e7aises) s\u00e9lectionn\u00e9es \u00e0 la suite de l\u2019appel de projets lanc\u00e9 par le Conseil Europ\u00e9en de l\u2019Innovation (the European Innovation Council, EIC) en novembre 2023 pour le programme \u00ab Accelerator \u00bb, qui r\u00e9compense des soci\u00e9t\u00e9s faisant preuve […]","og_url":"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/","og_site_name":"Tafalgie Therapeutics","article_published_time":"2024-03-19T17:16:35+00:00","article_modified_time":"2024-10-30T15:53:11+00:00","og_image":[{"width":2560,"height":1703,"url":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_94576008-scaled.jpeg","type":"image\/jpeg"}],"author":"Tafalgie_client_23","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Tafalgie_client_23","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/#article","isPartOf":{"@id":"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/"},"author":{"name":"Tafalgie_client_23","@id":"https:\/\/tafalgie.fr\/fr\/#\/schema\/person\/00336a1fe4b9683bda250c48cef99f56"},"headline":"Premier communiqu\u00e9 de presse","datePublished":"2024-03-19T17:16:35+00:00","dateModified":"2024-10-30T15:53:11+00:00","mainEntityOfPage":{"@id":"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/"},"wordCount":152,"publisher":{"@id":"https:\/\/tafalgie.fr\/fr\/#organization"},"image":{"@id":"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/#primaryimage"},"thumbnailUrl":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_94576008-scaled.jpeg","articleSection":["Communiqu\u00e9s de presse"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/","url":"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/","name":"Premier communiqu\u00e9 de presse - Tafalgie Therapeutics","isPartOf":{"@id":"https:\/\/tafalgie.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/#primaryimage"},"image":{"@id":"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/#primaryimage"},"thumbnailUrl":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_94576008-scaled.jpeg","datePublished":"2024-03-19T17:16:35+00:00","dateModified":"2024-10-30T15:53:11+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/#primaryimage","url":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_94576008-scaled.jpeg","contentUrl":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_94576008-scaled.jpeg"},{"@type":"WebSite","@id":"https:\/\/tafalgie.fr\/fr\/#website","url":"https:\/\/tafalgie.fr\/fr\/","name":"Tafalgie Therapeutics","description":"","publisher":{"@id":"https:\/\/tafalgie.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tafalgie.fr\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/tafalgie.fr\/fr\/#organization","name":"Tafalgie Therapeutics","url":"https:\/\/tafalgie.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/tafalgie.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/01\/logo-tafalgie-HD-02-1024x286-1.png","contentUrl":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/01\/logo-tafalgie-HD-02-1024x286-1.png","width":1024,"height":286,"caption":"Tafalgie Therapeutics"},"image":{"@id":"https:\/\/tafalgie.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/tafalgie.fr\/fr\/#\/schema\/person\/00336a1fe4b9683bda250c48cef99f56","name":"Tafalgie_client_23","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1777915955","url":"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1777915955","contentUrl":"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1777915955","caption":"Tafalgie_client_23"},"sameAs":["http:\/\/tafalgie.fr"],"url":"https:\/\/tafalgie.fr\/fr\/author\/tafalgie_client_23\/"}]}},"_links":{"self":[{"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/posts\/2131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/comments?post=2131"}],"version-history":[{"count":8,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/posts\/2131\/revisions"}],"predecessor-version":[{"id":2888,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/posts\/2131\/revisions\/2888"}],"wp:attachment":[{"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/media?parent=2131"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/categories?post=2131"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/tags?post=2131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}